SCHEMBL23327604

SCHEMBL23327604

O=c1[nH]nnc2c1sc1nc3ccccc3nc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ CYP1A2 P05177 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ PABPC1 P11940 1/20 0.37
▸ ADORA2A P29274 1/20 0.37
▸ ADORA2B P29275 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ PMP22 Q01453 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CHEK1 O14757 1/20 0.36
▸ MAPT P10636 2/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10633051 0.80 CHEK2 (0.41) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL23353118 0.76 KDM4E (0.48) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL23327889 0.69 TDP1 (0.39) KMT2AALDH1A1KDM4ERAB9AHSD17B10
SCHEMBL31683840 0.69 TDP1 (0.39) KMT2AALDH1A1KDM4ERAB9AHSD17B10
SCHEMBL10632720 0.65 SRC (0.44) MEN1KMT2AALDH1A1HPGDCYP2C19
SCHEMBL10520071 0.63 MEN1 (0.41) MEN1KMT2AALDH1A1HPGDKDM4E
SCHEMBL23353119 0.62 PDE4A (0.41) KMT2AALDH1A1KDM4EADORA2ARAB9A
SCHEMBL556965 0.62 TDP1 (0.59) MEN1KMT2AALDH1A1HPGDCYP1A2
SCHEMBL379982 0.62 PARP1 (0.48) KMT2AALDH1A1HPGDHSD17B10TDP1
SCHEMBL30067279 0.62 PARP1 (0.48) KMT2AALDH1A1HPGDHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 MEN1 2723/4885KMT2A 2958/4885ALDH1A1 184/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 MEN1 2723/4885KMT2A 2958/4885ALDH1A1 184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback